se ha leído el artículo
array:23 [ "pii" => "S1578219019301258" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.10.024" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "2108" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2019" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:337" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 35 "HTML" => 35 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731018305052" "issn" => "00017310" "doi" => "10.1016/j.ad.2018.10.011" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "2108" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:337" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 325 "formatos" => array:2 [ "HTML" => 212 "PDF" => 113 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>" "titulo" => "Carcinoma de células de Merkel, un tumor en auge" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "337" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The Rising Incidence of Merkel Cell Carcinoma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. Llombart" "autores" => array:1 [ 0 => array:2 [ "nombre" => "B." "apellidos" => "Llombart" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219019301258" "doi" => "10.1016/j.adengl.2018.10.024" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301258?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305052?idApp=UINPBA000044" "url" => "/00017310/0000011000000005/v1_201906020639/S0001731018305052/v1_201906020639/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S1578219019301428" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.12.011" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "2142" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:338" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "The Many Faces of Seborrheic Keratosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "338" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Las posibles mil caras de las queratosis seborreicas" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Carrera" "autores" => array:1 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Carrera" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731019300134" "doi" => "10.1016/j.ad.2018.12.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019300134?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301428?idApp=UINPBA000044" "url" => "/15782190/0000011000000005/v1_201906050857/S1578219019301428/v1_201906050857/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "The Rising Incidence of Merkel Cell Carcinoma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "337" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "B. Llombart" "autores" => array:1 [ 0 => array:3 [ "nombre" => "B." "apellidos" => "Llombart" "email" => array:1 [ 0 => "Beatriz.llombart@uv.es" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carcinoma de células de Merkel, un tumor en auge" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Merkel cell carcinoma (MCC) is considered an orphan disease due to its very low incidence. The article by Dañino-García et al.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> reports on a series of 38 patients with MCC treated at their hospital over a period of 16 years. The authors found a 116% increase in the number of cases diagnosed in the second half of the study and also observed an increase in the age of diagnosis and the occurrence of tumors at atypical sites. The increase in incidence is due to greater familiarity with the disease among dermatologists and pathologists and an increase in the at-risk population due to UV exposure, aging, and immunosuppression.</p><p id="par0010" class="elsevierStylePara elsevierViewall">MCC is a fast-growing, highly aggressive tumor characterized by early lymph node metastasis and high mortality. Mortality rates are much higher than for melanoma, for example, with a 10-year survival rate of 17.7% for MCC versus 61.3% for melanoma.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a> The overall 24-month survival rate in this series of 38 patients was 69.3% and the strongest prognostic factor was lymph node metastasis.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Effective medical treatment is needed for metastatic MCC. Conventional first-line chemotherapy is associated with response rates of between 30% and 55%, but response is short-lived (<span class="elsevierStyleBold"><<span class="elsevierStyleHsp" style=""></span></span>5 months).<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> Second-line chemotherapy does not offer any significant survival benefit, with a 12-month survival rate of 0%.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> The European Medicines Agency recently approved avelumab for the treatment of metastatic MCC. First-line avelumab induces rapid response in 62% to 74% of patients, and 52% of patients who receive this drug as second-line therapy are still alive at 12 months.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">3,4</span></a> The emergence of these new immunotherapy agents brings new hope to patients with MCC.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Llombart B. Carcinoma de células de Merkel, un tumor en auge. Actas Dermosifiliogr. 2019;110:337.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0025" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Características clínico-epidemiológicas del carcinoma de Merkel en una serie de 38 pacientes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Dañino-García" 1 => "J. Domínguez-Cruz" 2 => "C. Pérez-Ruiz" 3 => "J. Conejo-Mir" 4 => "J.J. Pereyra-Rodriguez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2018.09.007" "Revista" => array:2 [ "tituloSerie" => "Actas Dermosifilogr" "fecha" => "2018" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0030" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A comparison of Merkel cell carcinoma and melanoma: Results from the California Cancer Registry" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. Grabowski" 1 => "S.L. Saltzstein" 2 => "G.R. Salder" 3 => "Z. Tahir" 4 => "S. Blair" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Med Oncol" "fecha" => "2008" "volumen" => "2" "paginaInicial" => "327" "paginaFinal" => "333" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21892294" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0035" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C.L. Cowey" 1 => "L. Mahnke" 2 => "J. Espirito" 3 => "C. Helwig" 4 => "D. Oksen" 5 => "M. Bharmal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2217/fon-2017-0187" "Revista" => array:6 [ "tituloSerie" => "Future Oncol" "fecha" => "2017" "volumen" => "13" "paginaInicial" => "1699" "paginaFinal" => "1710" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28605939" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0040" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of advanced Merkel cell carcinoma: Current therapeutic options and novel immunotherapy approaches" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Femia" 1 => "N. Prinzi" 2 => "A. Anichini" 3 => "R. Mortarini" 4 => "F. Nichetti" 5 => "F. Corti" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Target Oncol" "fecha" => "2018" "volumen" => "13" "paginaInicial" => "567" "paginaFinal" => "582" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011000000005/v1_201906050857/S1578219019301258/v1_201906050857/en/main.assets" "Apartado" => array:4 [ "identificador" => "66476" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Commentaries" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000005/v1_201906050857/S1578219019301258/v1_201906050857/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301258?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 11 | 10 | 21 |
2024 Octubre | 65 | 29 | 94 |
2024 Septiembre | 67 | 18 | 85 |
2024 Agosto | 107 | 63 | 170 |
2024 Julio | 70 | 23 | 93 |
2024 Junio | 73 | 27 | 100 |
2024 Mayo | 63 | 31 | 94 |
2024 Abril | 59 | 21 | 80 |
2024 Marzo | 61 | 24 | 85 |
2024 Febrero | 44 | 28 | 72 |
2024 Enero | 58 | 32 | 90 |
2023 Diciembre | 40 | 14 | 54 |
2023 Noviembre | 62 | 24 | 86 |
2023 Octubre | 52 | 30 | 82 |
2023 Septiembre | 37 | 28 | 65 |
2023 Agosto | 27 | 13 | 40 |
2023 Julio | 33 | 34 | 67 |
2023 Junio | 36 | 21 | 57 |
2023 Mayo | 33 | 21 | 54 |
2023 Abril | 28 | 28 | 56 |
2023 Marzo | 27 | 19 | 46 |
2023 Febrero | 31 | 24 | 55 |
2023 Enero | 29 | 21 | 50 |
2022 Diciembre | 33 | 27 | 60 |
2022 Noviembre | 27 | 34 | 61 |
2022 Octubre | 27 | 22 | 49 |
2022 Septiembre | 19 | 34 | 53 |
2022 Agosto | 28 | 40 | 68 |
2022 Julio | 22 | 36 | 58 |
2022 Junio | 23 | 27 | 50 |
2022 Mayo | 33 | 27 | 60 |
2022 Abril | 38 | 34 | 72 |
2022 Marzo | 35 | 65 | 100 |
2022 Febrero | 36 | 22 | 58 |
2022 Enero | 34 | 40 | 74 |
2021 Diciembre | 25 | 28 | 53 |
2021 Noviembre | 37 | 40 | 77 |
2021 Octubre | 36 | 56 | 92 |
2021 Septiembre | 28 | 38 | 66 |
2021 Agosto | 25 | 21 | 46 |
2021 Julio | 20 | 18 | 38 |
2021 Junio | 17 | 12 | 29 |
2021 Mayo | 20 | 32 | 52 |
2021 Abril | 47 | 49 | 96 |
2021 Marzo | 55 | 16 | 71 |
2021 Febrero | 50 | 29 | 79 |
2021 Enero | 25 | 8 | 33 |
2020 Diciembre | 15 | 13 | 28 |
2020 Noviembre | 10 | 8 | 18 |
2020 Octubre | 11 | 10 | 21 |
2020 Septiembre | 29 | 6 | 35 |
2020 Agosto | 24 | 11 | 35 |
2020 Julio | 26 | 12 | 38 |
2020 Junio | 21 | 21 | 42 |
2020 Mayo | 16 | 12 | 28 |
2020 Abril | 16 | 8 | 24 |
2020 Marzo | 18 | 11 | 29 |
2020 Febrero | 1 | 0 | 1 |
2019 Noviembre | 35 | 0 | 35 |